Takahiko Sugiura
Overview
Explore the profile of Takahiko Sugiura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
964
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamaguchi K, Shijubo N, Kodama T, Mori K, Sugiura T, Kuriyama T, et al.
Jpn J Clin Oncol
. 2010 Nov;
41(1):148-52.
PMID: 21087977
Ectopic antidiuretic hormone syndrome is a medical emergency characterized by dilutional hyponatremia. Clinical effectiveness of the vasopressin V2 receptor antagonist mozavaptan was evaluated in 16 patients. In short-term (7-day) treatment...
2.
Sugiura H, Yamada K, Sugiura T, Hida T, Mitsudomi T
Clin Orthop Relat Res
. 2008 Jan;
466(3):729-36.
PMID: 18196360
The prognosis of patients with bone metastasis from lung cancer has not been well documented. We assessed the survival rates after bone metastasis and prognostic factors in 118 patients with...
3.
Yoshida K, Sugiura T, Takifuji N, Kawahara M, Matsui K, Kudoh S, et al.
Lung Cancer
. 2007 Aug;
58(3):362-8.
PMID: 17716779
To evaluate the efficacy and toxicity of three intrapleural therapy regimens consisting of bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or cisplatin plus etoposide (PE) for the...
4.
Kato E, Yamada N, Sugiura T
Kekkaku
. 2007 Jun;
82(5):481-5.
PMID: 17564128
A 30-year-old man suffered from a chest-pain on his left side and was also having a low-grade fever though he actually neglected these symptoms for a while. Later, he was...
5.
Kato E, Ishii A, Yamada N, Sugiura T
Nihon Kokyuki Gakkai Zasshi
. 2007 Jan;
44(12):1002-5.
PMID: 17233403
A 52-year-old asymptomatic man was referred to our hospital due to right pleural effusion detected on a chest X-ray mass screening. Chest X-ray film and chest CT showed moderate pleural...
6.
Yana T, Negoro S, Takada M, Yokota S, Takada Y, Sugiura T, et al.
Invest New Drugs
. 2006 Oct;
25(3):253-8.
PMID: 17039404
Purpose: To evaluate the efficacy and safety of amrubicin, (+)-(7S, 9S)-9-acetyl-9-amino-7-[(2-deoxy-beta-D-erythro-pentopyranosyl )oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione hydrochloride, in previously untreated patients with extensive-disease small cell lung cancer (SCLC). Patients And Methods: A total of...
7.
Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, et al.
Cancer
. 2006 Jun;
107(3):599-605.
PMID: 16804877
Background: Combined gemcitabine and carboplatin (GC) and combined gemcitabine and vinorelbine (GV) are active and well tolerated chemotherapeutic regimens for patients with advanced nonsmall cell lung cancer (NSCLC). The authors...
8.
Sawa T, Yana T, Takada M, Sugiura T, Kudoh S, Kamei T, et al.
Invest New Drugs
. 2006 Feb;
24(2):151-8.
PMID: 16502350
Purpose: Amrubicin is a novel 9-aminoanthracycline. This multicenter phase II study was conducted to evaluate the efficacy and safety of amrubicin in patients with non-small-cell lung cancer (NSCLC). Patients And...
9.
Kubota K, Nishiwaki Y, Sugiura T, Noda K, Mori K, Kawahara M, et al.
Clin Cancer Res
. 2005 Aug;
11(15):5534-8.
PMID: 16061870
Purpose: Irinotecan and cisplatin (IP) significantly improved survival compared with etoposide and cisplatin (EP), in patients with extensive-stage small cell lung cancer (SCLC) in a previous Japan Clinical Oncology Group...
10.
Sugiura T, Ariyoshi Y, Negoro S, Nakamura S, Ikegami H, Takada M, et al.
Invest New Drugs
. 2005 Jul;
23(4):331-7.
PMID: 16012792
Purpose: Amrubicin is a novel, totally synthetic 9-aminoanthracycline. The present phase I/II study was performed to define its maximum-tolerated dose (MTD), efficacy and toxicity in the treatment of previously untreated...